- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 42 x LDA: LAURYL DIMETHYLAMINE-N-OXIDE(Non-covalent)(Non-functional Binders)
LDA.2: 4 residues within 4Å:- Chain A: T.124
- Ligands: LDA.26, LDA.33, LDA.36
Ligand excluded by PLIPLDA.3: 7 residues within 4Å:- Chain A: Y.15, I.17, Y.58, E.254, A.273, G.274, V.275
Ligand excluded by PLIPLDA.11: 5 residues within 4Å:- Chain A: R.45, H.75, K.114, D.118, W.132
Ligand excluded by PLIPLDA.12: 10 residues within 4Å:- Chain A: E.16, R.169, T.208, Y.210, R.212, R.236, F.240, E.254, Y.272
- Ligands: LDA.50
Ligand excluded by PLIPLDA.13: 9 residues within 4Å:- Chain A: L.239, Y.241, L.253, Y.255, F.257, H.271
- Ligands: LDA.14, LDA.32, LDA.45
Ligand excluded by PLIPLDA.14: 4 residues within 4Å:- Chain A: L.253, H.271
- Ligands: LDA.13, LDA.32
Ligand excluded by PLIPLDA.15: 6 residues within 4Å:- Chain A: V.170, I.194, G.214, L.215, D.233
- Ligands: LDA.22
Ligand excluded by PLIPLDA.16: 9 residues within 4Å:- Chain A: Y.97, T.145, G.146, Y.147, R.151, E.175, F.189, W.221
- Ligands: LDA.43
Ligand excluded by PLIPLDA.17: 3 residues within 4Å:- Chain A: W.7, A.39
- Ligands: LDA.38
Ligand excluded by PLIPLDA.18: 4 residues within 4Å:- Chain A: W.7, N.41, W.44, V.74
Ligand excluded by PLIPLDA.19: 8 residues within 4Å:- Chain A: W.44, V.74, Y.76, F.78, L.88, T.89, G.90
- Ligands: LDA.47
Ligand excluded by PLIPLDA.20: 12 residues within 4Å:- Chain A: A.13, M.14, Y.15, P.33, S.34, V.35, Y.50, Q.52, V.275, G.276, V.277
- Ligands: LDA.39
Ligand excluded by PLIPLDA.21: 6 residues within 4Å:- Chain A: F.129, T.156, Y.172, L.174, Q.192
- Ligands: LDA.30
Ligand excluded by PLIPLDA.22: 3 residues within 4Å:- Chain A: L.215
- Ligands: LDA.15, LDA.36
Ligand excluded by PLIPLDA.23: 4 residues within 4Å:- Chain A: P.70, F.92, N.109
- Ligands: LDA.37
Ligand excluded by PLIPLDA.24: 6 residues within 4Å:- Chain A: L.72, V.74, G.91, F.92, Q.111, N.140
Ligand excluded by PLIPLDA.25: 4 residues within 4Å:- Chain A: L.202, H.205, Y.241
- Ligands: LDA.48
Ligand excluded by PLIPLDA.26: 4 residues within 4Å:- Chain A: L.123, T.124
- Ligands: LDA.2, LDA.33
Ligand excluded by PLIPLDA.27: 5 residues within 4Å:- Chain A: L.158, Y.160, L.168, V.170
- Ligands: LDA.36
Ligand excluded by PLIPLDA.28: 2 residues within 4Å:- Chain A: F.178
- Ligands: LDA.30
Ligand excluded by PLIPLDA.29: 6 residues within 4Å:- Chain A: G.91, I.115, M.135, Y.136, K.137, M.180
Ligand excluded by PLIPLDA.30: 5 residues within 4Å:- Chain A: W.119, F.129
- Ligands: LDA.21, LDA.28, LDA.41
Ligand excluded by PLIPLDA.31: 7 residues within 4Å:- Chain A: F.37, L.48
- Ligands: LDA.35, LDA.37, LDA.38, LDA.39, LDA.44
Ligand excluded by PLIPLDA.32: 2 residues within 4Å:- Ligands: LDA.13, LDA.14
Ligand excluded by PLIPLDA.33: 2 residues within 4Å:- Ligands: LDA.2, LDA.26
Ligand excluded by PLIPLDA.34: 5 residues within 4Å:- Chain A: I.11, G.12, Y.279
- Ligands: LDA.44, LDA.46
Ligand excluded by PLIPLDA.35: 10 residues within 4Å:- Chain A: V.35, Y.36, F.37, L.48, A.49, Y.50, D.68
- Ligands: LDA.31, LDA.37, LDA.39
Ligand excluded by PLIPLDA.36: 3 residues within 4Å:- Ligands: LDA.2, LDA.22, LDA.27
Ligand excluded by PLIPLDA.37: 6 residues within 4Å:- Chain A: Y.50, D.68, P.70
- Ligands: LDA.23, LDA.31, LDA.35
Ligand excluded by PLIPLDA.38: 5 residues within 4Å:- Chain A: F.9, F.37, F.281
- Ligands: LDA.17, LDA.31
Ligand excluded by PLIPLDA.39: 4 residues within 4Å:- Chain A: V.35
- Ligands: LDA.20, LDA.31, LDA.35
Ligand excluded by PLIPLDA.40: 6 residues within 4Å:- Chain A: A.196, L.198, P.209, Y.210, T.211
- Ligands: LDA.49
Ligand excluded by PLIPLDA.41: 4 residues within 4Å:- Chain A: N.81, D.83, F.84
- Ligands: LDA.30
Ligand excluded by PLIPLDA.42: 3 residues within 4Å:- Chain A: L.202, V.207
- Ligands: LDA.48
Ligand excluded by PLIPLDA.43: 5 residues within 4Å:- Chain A: E.25, W.221, Q.260, H.262
- Ligands: LDA.16
Ligand excluded by PLIPLDA.44: 4 residues within 4Å:- Chain A: I.11, F.281
- Ligands: LDA.31, LDA.34
Ligand excluded by PLIPLDA.45: 7 residues within 4Å:- Chain A: V.237, G.238, L.239, Y.255, W.259
- Ligands: LDA.13, LDA.49
Ligand excluded by PLIPLDA.46: 3 residues within 4Å:- Chain A: N.247, Y.279
- Ligands: LDA.34
Ligand excluded by PLIPLDA.47: 3 residues within 4Å:- Chain A: F.78, L.79
- Ligands: LDA.19
Ligand excluded by PLIPLDA.48: 3 residues within 4Å:- Chain A: L.202
- Ligands: LDA.25, LDA.42
Ligand excluded by PLIPLDA.49: 3 residues within 4Å:- Chain A: W.259
- Ligands: LDA.40, LDA.45
Ligand excluded by PLIPLDA.50: 7 residues within 4Å:- Chain A: N.10, M.14, F.240, S.252, N.278, S.280
- Ligands: LDA.12
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yildiz, O. et al., Structure of the Monomeric Outer-Membrane Porin Ompg in the Open and Closed Conformation. Embo J. (2006)
- Release Date
- 2006-08-14
- Peptides
- OUTER MEMBRANE PROTEIN G: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 8 x CA: CALCIUM ION(Non-covalent)
- 42 x LDA: LAURYL DIMETHYLAMINE-N-OXIDE(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yildiz, O. et al., Structure of the Monomeric Outer-Membrane Porin Ompg in the Open and Closed Conformation. Embo J. (2006)
- Release Date
- 2006-08-14
- Peptides
- OUTER MEMBRANE PROTEIN G: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
C - Membrane
-
We predict this structure to be a membrane protein.